Kaye, Emily G. http://orcid.org/0000-0002-5889-1913
Basavaraju, Kavyashree http://orcid.org/0000-0001-9517-0552
Nelson, Geoffrey M. http://orcid.org/0000-0001-9825-4241
Zomer, Helena D.
Roy, Debarun
Joseph, Irene Infancy
Rajabi-Toustani, Reza
Qiao, Huanyu http://orcid.org/0000-0003-0966-8077
Adelman, Karen http://orcid.org/0000-0001-5364-334X
Reddi, Prabhakara P. http://orcid.org/0000-0003-4891-8964
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | Eunice Kennedy Shriver National Institute of Child Health and Human Development (R01HD094546, R01HD36239)
U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (R01GM135549)
Article History
Received: 1 May 2023
Accepted: 16 January 2024
First Online: 29 January 2024
Competing interests
: K.A. received research funding from Novartis not related to this work, is a consultant for Odyssey Therapeutics, and is on the SAB of CAMP4 Therapeutics. The remaining authors declare no competing interests.